TPX-100 is OrthoTrophix's lead therapeutic candidate and is being developed as a potential disease-modifying osteoarthritis drug (DMOAD) -- designed not only to improve symptoms, but also to slow or ...
Tempur Sealy International, Inc. (NYSE:TPX) Q4 2025 Earnings Call Transcript February 17, 2026 Aubrey Moore: Good morning, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results